Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p8)

Talk to Amrita

+1 718 303 2019

Search inside this page

You might be interested in: therapeutics, drug, cancer, more »

211-260 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Australia Pharmaceuticals and Healthcare Report Q1 2014

Australia Pharmaceuticals and Healthcare Report Q1 2014

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We maintain our broad view toward Australia's pharmaceutical and healthcare sectors, as new Prime Minister Tony Abbott stated that 'there will be no cuts to ...

  • Industries : Drug and Medication
  • Countries : Australia
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

  • $ 3 500
  • Industry report
  • January 2014
  • by GBI Research

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : World, Australia, Japan, India, China
Chemical & Pharmaceutical Plants Construction in New Zealand to 2017: Market Databook

Chemical & Pharmaceutical Plants Construction in New Zealand to 2017: Market Databook

  • $ 500
  • Industry report
  • January 2014
  • by Timetric

Synopsis Timetric's 'Chemical & Pharmaceutical Plants Construction in New Zealand to 2017: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Orphan Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Orphan Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Orphan Australia Pty Ltd (Orphan Australia) is a pharmaceutical company. The company provides novel therapies for the treatment of serious or life-threatening diseases in Australia and New Zealand. ...

  • Industries : Pharmaceutical
  • Countries : Australia
Catalent Pharma Solutions, Inc. - Strategic SWOT Analysis Review

Catalent Pharma Solutions, Inc. - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Catalent Pharma Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains ...

  • Industries : Drug Delivery Technology
  • Countries : China, United States, Australia, Malaysia
Novogen Limited (Symbol:NRT) SWOT Analysis, Strategy, Revenues and Profits

Novogen Limited (Symbol:NRT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Ministry of Health, New Zealand - Strategic SWOT Analysis Review

Ministry of Health, New Zealand - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Ministry of Health, New Zealand - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains ...

  • Industries : Pathology
  • Countries : New Zealand
Avexa Limited (Symbol:AVX) SWOT Analysis, Strategy, Revenues and Profits

Avexa Limited (Symbol:AVX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia
Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

Aspen Pharmacare Holdings Ltd (Symbol:APN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia, South Africa, World, Brazil, Mexico, Germany, Tanzania, Kenya, Africa, Venezuela, Mauritius
Antisense Therapeutics Limited (Symbol:ANP) SWOT Analysis, Strategy, Revenues and Profits

Antisense Therapeutics Limited (Symbol:ANP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Australia, United States
Hexima Limited - Strategic SWOT Analysis Review

Hexima Limited - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • January 2014
  • by Global Data

Hexima Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, ...

  • Industries : Drug Delivery Technology
  • Countries : Australia
IDT Australia Limited (Symbol:IDT) SWOT Analysis, Strategy, Revenues and Profits

IDT Australia Limited (Symbol:IDT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia
Sigma Pharmaceuticals Limited - Strategy and SWOT Report

Sigma Pharmaceuticals Limited - Strategy and SWOT Report

  • $ 175
  • Company report
  • January 2014
  • by MarketLine

Sigma Pharmaceuticals Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmaceuticals Market Analysis in Australia: ISIC 2423

Pharmaceuticals Market Analysis in Australia: ISIC 2423

  • $ 599
  • Industry report
  • January 2014
  • by Euromonitor International

Euromonitor International's Industrial reports provide a 360 degree view of an market . The Industrial industry report offers a comprehensive guide to the size and shape of the Pharmaceuticalsmarket at ...

  • Industries : Pharmaceutical
  • Countries : Australia
Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review

Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • December 2013
  • by Global Data

Solagran Limited (SLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Pathology
  • Countries : Australia
Blackmores Limited (Symbol:BKL) SWOT Analysis, Strategy, Revenues and Profits

Blackmores Limited (Symbol:BKL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : Australia, South Korea, New Zealand, Singapore
Genera Biosystems Limited (GBI) - Product Pipeline Analysis, 2013 Update

Genera Biosystems Limited (GBI) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • December 2013
  • by Global Data

Summary Genera Biosystems Limited (GBL) is a diagnostic product company. The company develops and commercializes multiplexed molecular diagnostic testing products. Its products include RTIplex and PapType. ...

  • Industries : Pathology
  • Countries : Australia
Biosceptre International Limited - Product Pipeline Analysis, 2013 Update

Biosceptre International Limited - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • December 2013
  • by Global Data

Summary Biosceptre International Limited (Biosceptre) is a biotechnology company. The company develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. ...

  • Industries : Pathology
  • Countries : Australia
Pacific Edge Limited (PEB) - Product Pipeline Analysis, 2013 Update

Pacific Edge Limited (PEB) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • December 2013
  • by Global Data

Summary Pacific Edge Limited (PEB) is a cancer diagnostics service provider. The company discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. ...

  • Industries : Pathology
  • Countries : New Zealand, United States
Contact Dermatitis - Pipeline Review, H2 2013

Contact Dermatitis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Contact Dermatitis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Contact Dermatitis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World, South Korea, New Zealand, Australia
Dilated Cardiomyopathy - Pipeline Review, H2 2013

Dilated Cardiomyopathy - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Dilated Cardiomyopathy - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Dilated Cardiomyopathy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World, Australia
Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2013

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • November 2013
  • by Global Markets Direct

Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Haemophilus Influenzae Type b Infections - Pipeline Review, H2 2013', provides an overview of the indication's ...

  • Industries : Drug and Medication
  • Countries : India, World, Australia
Auto Inflammatory Disease - Pipeline Review, H2 2013

Auto Inflammatory Disease - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • November 2013
  • by Global Markets Direct

Auto Inflammatory Disease - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Auto Inflammatory Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Therapy
  • Countries : World, Australia
Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use

Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use

  • $ 3 500
  • Industry report
  • November 2013
  • by GBI Research

Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use Summary GBI Research has released its pharmaceutical ...

  • Industries : Pathology
  • Countries : World, Australia, India, Japan, China, Asia
New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2013
  • by Business Monitor International

BMI View: While New Zealand has a highly developed healthcare services system, its pharmaceutical industry is not a particularly attractive prospect for multinationals. Even though the country’s risk ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Bafna Pharmaceuticals Limited (Symbol:532989) SWOT Analysis, Strategy, Revenues and Profits

Bafna Pharmaceuticals Limited (Symbol:532989) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : India, Philippines, Australia, Sri Lanka, World
Global Market for Polyethylene Glycol Waxes to 2017 - Market Size, Growth and Forecasts in Nearly 70 Countries

Global Market for Polyethylene Glycol Waxes to 2017 - Market Size, Growth and Forecasts in Nearly 70 Countries

  • $ 1 238
  • Industry report
  • November 2013
  • by MarketSizeInfo

This comprehensive publication enables readers the critical perspectives to be able to evaluate the world market for polyethylene glycol waxes. The publication provides the market size, growth and forecasts ...

  • Industries : Over-the-counter Drug
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Senegal, Morocco, Ghana, Ethiopia, Kyrgyz Republic (kyrgyzstan), North America, Peru, Oman
Chemical & Pharmaceutical Plants Construction in Australia to 2017: Market Databook

Chemical & Pharmaceutical Plants Construction in Australia to 2017: Market Databook

  • $ 500
  • Industry report
  • November 2013
  • by Timetric

Synopsis Timetric's 'Chemical & Pharmaceutical Plants Construction in Australia to 2017: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants ...

  • Industries : Pharmaceutical
  • Countries : Australia
Emerging NIPT Market in Asia Pacific

Emerging NIPT Market in Asia Pacific

  • $ 1 200
  • Industry report
  • November 2013
  • by RNCOS

Non-Invasive Prenatal Testing (NIPT) has catapulted the growth in the molecular diagnostics market. In the US, where the test was initially launched, the market is expected to grow at a CAGR of 49% during ...

  • Industries : Drug Discovery and Development
  • Countries : Australia, Japan, China, Asia, World, Oceania, India, United States
Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)

Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)

  • $ 800
  • Industry report
  • November 2013
  • by Daedal Research

Scope of the report The report titled “Global Age-Related Macular Degeneration (AMD) Market: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global age-related macular degeneration ...

  • Industries : Pathology
  • Countries : World, Australia

13 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Management Strategies

United States

Abbott Laboratories

United States

Medtronic Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.